Login / Signup

Molidustat for the treatment of renal anaemia in patients with dialysis-dependent chronic kidney disease: design and rationale of three phase III studies.

Tadao AkizawaMegumi TaguchiYoshimi MatsudaKazuma IekushiTakashi YamadaHiroyasu Yamamoto
Published in: BMJ open (2019)
NCT03351166; Pre-results, NCT03418168; Pre-results, NCT03543657; Pre-results.
Keyphrases
  • chronic kidney disease
  • phase iii
  • end stage renal disease
  • clinical trial
  • open label
  • randomized controlled trial
  • placebo controlled
  • case control
  • study protocol